Announcements
-
Announcing the 2023 Dermatitis® Articles of the Year
Dermatitis® Article of the Year
Assessment of Contact Allergens in ‘‘Hypoallergenic’’ Athletic Shoes by Mass Spectrometry - Read Now2nd Place Runner-Up
Patch Testing in Patients with Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain - Read Now3rd Place Runner-Up
Occupational Hand Dermatitis in Health Care: Development and Evaluation of an Online Training E-Module - Read NowDermatitis® Review Article of the Year
Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review - Read Now -
CALLS FOR PAPERS
- Dermatitis® is seeking articles that focus on Skin of Color and the optimization of care for all patients by highlighting diversity, equity, inclusion efforts and/or healthcare disparities in patients with contact, atopic, occupational, drug, or environmental dermatitis. Articles should fall into one of these categories: studies, reviews, letters, Pearls & Zebras, and Images.
- Upload your paper using the manuscript category: "Special Issue: DEI Initiatives".
Dermatitis® Special Issue Focused on Skin of Color and DEI Initiatives
-
CALLS FOR PAPERS
- Dermatitis® is seeking manuscripts that will provide practical techniques to its members related to procedures to diagnose cutaneous allergy, whether it is contact dermatitis, type I allergic reactions, reactions to environmental agents or systemic reactions to medications.
- Upload your paper using the manuscript category: "Practical Techniques"
Dermatitis® New Article Type: Practical Techniques
Aims & Scope
Dermatitis® is the leading peer-reviewed scientific journal in contact dermatitis, and is the only journal in its field that publishes leading research in atopic, contact, occupational, environmental, and drug dermatitis.
International in scope, the journal publishes research related to immunobiology of atopic dermatitis therapy, descriptions of important findings that result from clinical, translational, or basic research related to the mentioned types of dermatitis, epidemiology and population studies, health care disparities, skin of color, and allergy/patch testing in atopic dermatitis. The journal welcomes manuscript submissions in these fields, with emphasis on original research, review papers, case studies, and reports. The journal serves as a foremost resource to dermatologists, allergists, immunologists, and toxicologists.
Dermatitis® is owned by the American Contact Dermatitis Society (ACDS) and is the central resource of four organizations, namely Societa Italiana di Dermatologica Allergologica Professionale e Ambientale (SIDAPA), Experimental Contact Dermatitis Research Group (ECDRG), International Contact Dermatitis Research Group (ICDRG), and the North American Contact Dermatitis Group (NACDG).
An annual subscription to Dermatitis® is a benefit of membership in the ACDS. For more information on the benefits of becoming a member, please visit the ACDS website.
Indexing/Abstracting:
- PubMed/MEDLINE
- PubMed Central
- Web of Science: Science Citation Index Expanded™ (SCIE)
- Scopus
- EMBASE/Excerpta Medica